Company news

Renalytix PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Q3 Trading Update

April 10, 2025

Notice of Interim Results & Investor Presentation

March 12, 2025

Publication in journal (JASN) for kidneyIntelX.dkd

February 6, 2025

Trading Update

January 27, 2025

Foreign Private Issuer re-qualification

January 17, 2025

Grant & Cancellation of Options

December 30, 2024

Director/PDMR share purchase

December 20, 2024

AGM Statement

December 19, 2024

Director/PDMR dealings

December 11, 2024

Directorate Change

December 2, 2024

Publication of Annual Report and Notice of AGM

November 26, 2024

Audited Full Year Fiscal 2024 Results

November 21, 2024

Financial Results for Q1 of Fiscal Year 2025

November 20, 2024

Cancellation of Ordinary Shares & TVR

November 6, 2024

Result of General Meeting

October 31, 2024

Posting of Circular & Notice of GM

October 11, 2024

Admission of Shares & Total Voting Rights

October 8, 2024

Result of Placing and Subscription

October 1, 2024

Placing and Subscription

September 30, 2024

Change of Adviser

August 30, 2024

Nasdaq Grants Listing Extension

August 27, 2024

Appointment of Joint Corporate Broker

August 21, 2024

Termination of Formal Sale Process

August 20, 2024

Total Voting Rights

July 30, 2024

Issue of Shares and Rule 2.9 Announcement

July 15, 2024

Steno Diabetes Center (Copenhagen) Collaboration

July 11, 2024

Admission of the Second Tranche Placing Shares

July 1, 2024

Nasdaq Delisting Determination - Appeal update

June 28, 2024

Change of public accounting firm

June 25, 2024

Medicare issues final Local Coverage Determination

June 14, 2024

PDMR Dealing

June 13, 2024

Management Change

May 28, 2024

Block Admission & “At The Market” Sales Agreement

May 21, 2024

Renalytix Reports Financial Results for Q3 FY2024

May 15, 2024

Notice of Q3 Results

May 9, 2024

Admission of the First Tranche Placing Shares

April 29, 2024

Allotment and issue of Second Tranche Shares

April 25, 2024

Rule 2.9 Announcement

April 16, 2024

Completion of Financing and Total Voting Rights

April 15, 2024

Issue of Shares

April 10, 2024

Financing with Expected Size of up to $4 Million

April 8, 2024

Change of Registered Address

April 5, 2024

Notice of GM

April 3, 2024

Rule 2.9 announcement

March 15, 2024

KidneyIntelX™ included in KDIGO 2024 Guideline

March 14, 2024

Successful completion of upsized $12m placing

March 12, 2024

Approach from Possible Strategic Acquiror

March 4, 2024

Grant of Share Options - replacement

March 1, 2024

US Government coverage expanded

February 29, 2024

Half Year Report

February 15, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks